328 related articles for article (PubMed ID: 19898734)
21. Low-density lipoprotein receptor-related protein 5 polymorphisms are associated with bone mineral density in Greek postmenopausal women: an interaction with calcium intake.
Stathopoulou MG; Dedoussis GV; Trovas G; Katsalira A; Hammond N; Deloukas P; Lyritis GP
J Am Diet Assoc; 2010 Jul; 110(7):1078-83. PubMed ID: 20630166
[TBL] [Abstract][Full Text] [Related]
22. Raloxifene pharmacodynamics is influenced by genetic variants in the RANKL/RANK/OPG system and in the Wnt signaling pathway.
Mencej-Bedrač S; Zupan J; Mlakar SJ; Zavratnik A; Preželj J; Marc J
Drug Metabol Drug Interact; 2014; 29(2):111-4. PubMed ID: 24615483
[TBL] [Abstract][Full Text] [Related]
23. A common LRP4 haplotype is associated with bone mineral density and hip geometry in men-data from the Odense Androgen Study (OAS).
Boudin E; Steenackers E; de Freitas F; Nielsen TL; Andersen M; Brixen K; Van Hul W; Piters E
Bone; 2013 Apr; 53(2):414-20. PubMed ID: 23321396
[TBL] [Abstract][Full Text] [Related]
24. Association of a single-nucleotide polymorphism in low-density lipoprotein receptor-related protein 5 gene with bone mineral density.
Urano T; Shiraki M; Ezura Y; Fujita M; Sekine E; Hoshino S; Hosoi T; Orimo H; Emi M; Ouchi Y; Inoue S
J Bone Miner Metab; 2004; 22(4):341-5. PubMed ID: 15221492
[TBL] [Abstract][Full Text] [Related]
25. Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity.
Ellies DL; Viviano B; McCarthy J; Rey JP; Itasaki N; Saunders S; Krumlauf R
J Bone Miner Res; 2006 Nov; 21(11):1738-49. PubMed ID: 17002572
[TBL] [Abstract][Full Text] [Related]
26. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass.
Morvan F; Boulukos K; Clément-Lacroix P; Roman Roman S; Suc-Royer I; Vayssière B; Ammann P; Martin P; Pinho S; Pognonec P; Mollat P; Niehrs C; Baron R; Rawadi G
J Bone Miner Res; 2006 Jun; 21(6):934-45. PubMed ID: 16753024
[TBL] [Abstract][Full Text] [Related]
27. Functional relevance of the BMD-associated polymorphism rs312009: novel involvement of RUNX2 in LRP5 transcriptional regulation.
Agueda L; Velázquez-Cruz R; Urreizti R; Yoskovitz G; Sarrión P; Jurado S; Güerri R; Garcia-Giralt N; Nogués X; Mellibovsky L; Díez-Pérez A; Marie PJ; Balcells S; Grinberg D
J Bone Miner Res; 2011 May; 26(5):1133-44. PubMed ID: 21542013
[TBL] [Abstract][Full Text] [Related]
28. Association study of polymorphisms in the SOST gene region and parameters of bone strength and body composition in both young and elderly men: data from the Odense Androgen Study.
Piters E; de Freitas F; Nielsen TL; Andersen M; Brixen K; Van Hul W
Calcif Tissue Int; 2012 Jan; 90(1):30-9. PubMed ID: 22076526
[TBL] [Abstract][Full Text] [Related]
29. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis.
van Meurs JB; Trikalinos TA; Ralston SH; Balcells S; Brandi ML; Brixen K; Kiel DP; Langdahl BL; Lips P; Ljunggren O; Lorenc R; Obermayer-Pietsch B; Ohlsson C; Pettersson U; Reid DM; Rousseau F; Scollen S; Van Hul W; Agueda L; Akesson K; Benevolenskaya LI; Ferrari SL; Hallmans G; Hofman A; Husted LB; Kruk M; Kaptoge S; Karasik D; Karlsson MK; Lorentzon M; Masi L; McGuigan FE; Mellström D; Mosekilde L; Nogues X; Pols HA; Reeve J; Renner W; Rivadeneira F; van Schoor NM; Weber K; Ioannidis JP; Uitterlinden AG;
JAMA; 2008 Mar; 299(11):1277-90. PubMed ID: 18349089
[TBL] [Abstract][Full Text] [Related]
30. No association between hip geometry and four common polymorphisms associated with fracture: the Danish osteoporosis prevention study.
Nissen N; Madsen JS; Bladbjerg EM; Beck Jensen JE; Jørgensen NR; Langdahl B; Abrahamsen B; Brixen K
Calcif Tissue Int; 2009 Apr; 84(4):276-85. PubMed ID: 19225709
[TBL] [Abstract][Full Text] [Related]
31. A1330V variant of the low-density lipoprotein receptor-related protein 5 (LRP5) gene decreases Wnt signaling and affects the total body bone mineral density in Japanese women.
Urano T; Shiraki M; Usui T; Sasaki N; Ouchi Y; Inoue S
Endocr J; 2009; 56(4):625-31. PubMed ID: 19571442
[TBL] [Abstract][Full Text] [Related]
32. Analysis of three functional polymorphisms in relation to osteoporosis phenotypes: replication in a Spanish cohort.
Agueda L; Urreizti R; Bustamante M; Jurado S; Garcia-Giralt N; Díez-Pérez A; Nogués X; Mellibovsky L; Grinberg D; Balcells S
Calcif Tissue Int; 2010 Jul; 87(1):14-24. PubMed ID: 20390408
[TBL] [Abstract][Full Text] [Related]
33. Influence of an LRP5 cytoplasmic SNP on Wnt signaling and osteoblastic differentiation.
Guo J; Cooper LF
Bone; 2007 Jan; 40(1):57-67. PubMed ID: 16956801
[TBL] [Abstract][Full Text] [Related]
34. The A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene (LRP5) associates with low peak bone mass in young healthy men.
Saarinen A; Välimäki VV; Välimäki MJ; Löyttyniemi E; Auro K; Uusen P; Kuris M; Lehesjoki AE; Mäkitie O
Bone; 2007 Apr; 40(4):1006-12. PubMed ID: 17223614
[TBL] [Abstract][Full Text] [Related]
35. Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness.
Thambiah S; Roplekar R; Manghat P; Fogelman I; Fraser WD; Goldsmith D; Hampson G
Calcif Tissue Int; 2012 Jun; 90(6):473-80. PubMed ID: 22527202
[TBL] [Abstract][Full Text] [Related]
36. A haplotype-based analysis of the LRP5 gene in relation to osteoporosis phenotypes in Spanish postmenopausal women.
Agueda L; Bustamante M; Jurado S; Garcia-Giralt N; Ciria M; Saló G; Carreras R; Nogués X; Mellibovsky L; Díez-Pérez A; Grinberg D; Balcells S
J Bone Miner Res; 2008 Dec; 23(12):1954-63. PubMed ID: 18684085
[TBL] [Abstract][Full Text] [Related]
37. Association between polymorphisms in Wnt signaling pathway genes and bone mineral density in postmenopausal Korean women.
Lee DY; Kim H; Ku SY; Kim SH; Choi YM; Kim JG
Menopause; 2010; 17(5):1064-70. PubMed ID: 20613673
[TBL] [Abstract][Full Text] [Related]
38. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
[TBL] [Abstract][Full Text] [Related]
39. Bone Matrix Levels of Dickkopf and Sclerostin are Positively Correlated with Bone Mass and Strength in Postmenopausal Osteoporosis.
Ueland T; Stilgren L; Bollerslev J
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31197079
[TBL] [Abstract][Full Text] [Related]
40. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.
Li J; Sarosi I; Cattley RC; Pretorius J; Asuncion F; Grisanti M; Morony S; Adamu S; Geng Z; Qiu W; Kostenuik P; Lacey DL; Simonet WS; Bolon B; Qian X; Shalhoub V; Ominsky MS; Zhu Ke H; Li X; Richards WG
Bone; 2006 Oct; 39(4):754-66. PubMed ID: 16730481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]